OBJECTIVE: To identify factors that influence the total and negative lymph node counts in colorectal cancer resection specimens independent of pathologists and surgeons. DESIGN: We used multivariate negative binomial regression. Covariates included age, sex, body mass index, family history of colorectal carcinoma, year of diagnosis, hospital setting, tumor location, resected colorectal length (specimen length), tumor size, circumferential growth, TNM stage, lymphocytic reactions and other pathological features, and tumor molecular features (microsatellite instability, CpG island methylator phenotype, long interspersed nucleotide element 1 [LINE-1] methylation, and BRAF, KRAS, and PIK3CA mutations). SETTING: Two US nationwide prospective cohort studies. PATIENTS: Patients with rectal and colon cancer (N=918). MAIN OUTCOME MEASURES: The negative and total node counts (continuous). RESULTS: Specimen length, tumor size, ascending colon location, T3N0M0 stage, and year of diagnosis were positively associated with the negative node count (all P.002). Mutation of KRAS might also be positively associated with the negative node count (P=.03; borderline significance considering multiple hypothesis testing). Among node-negative (stages I and II) cases, specimen length, tumor size, and ascending colon location remained significantly associated with the node count (all P.002), and PIK3CA and KRAS mutations might also be positively associated (P=.03 and P=.049, respectively, with borderline significance). CONCLUSIONS: This molecular pathological epidemiology study shows that specimen length, tumor size, tumor location, TNM stage, and year of diagnosis are operator-independent predictors of the lymph node count. These crucial variables should be examined in any future evaluation of the adequacy of lymph node harvest and nodal staging when devising individualized treatment plans for patients with colorectal cancer.
OBJECTIVE: To identify factors that influence the total and negative lymph node counts in colorectal cancer resection specimens independent of pathologists and surgeons. DESIGN: We used multivariate negative binomial regression. Covariates included age, sex, body mass index, family history of colorectal carcinoma, year of diagnosis, hospital setting, tumor location, resected colorectal length (specimen length), tumor size, circumferential growth, TNM stage, lymphocytic reactions and other pathological features, and tumor molecular features (microsatellite instability, CpG island methylator phenotype, long interspersed nucleotide element 1 [LINE-1] methylation, and BRAF, KRAS, and PIK3CA mutations). SETTING: Two US nationwide prospective cohort studies. PATIENTS: Patients with rectal and colon cancer (N=918). MAIN OUTCOME MEASURES: The negative and total node counts (continuous). RESULTS: Specimen length, tumor size, ascending colon location, T3N0M0 stage, and year of diagnosis were positively associated with the negative node count (all P.002). Mutation of KRAS might also be positively associated with the negative node count (P=.03; borderline significance considering multiple hypothesis testing). Among node-negative (stages I and II) cases, specimen length, tumor size, and ascending colon location remained significantly associated with the node count (all P.002), and PIK3CA and KRAS mutations might also be positively associated (P=.03 and P=.049, respectively, with borderline significance). CONCLUSIONS: This molecular pathological epidemiology study shows that specimen length, tumor size, tumor location, TNM stage, and year of diagnosis are operator-independent predictors of the lymph node count. These crucial variables should be examined in any future evaluation of the adequacy of lymph node harvest and nodal staging when devising individualized treatment plans for patients with colorectal cancer.
Authors: Shuji Ogino; Katsuhiko Nosho; Gregory J Kirkner; Takako Kawasaki; Jeffrey A Meyerhardt; Massimo Loda; Edward L Giovannucci; Charles S Fuchs Journal: Gut Date: 2008-10-02 Impact factor: 23.059
Authors: Paris P Tekkis; Jason J Smith; Alexander G Heriot; Ara W Darzi; Michael R Thompson; Jeffrey D Stamatakis Journal: Dis Colon Rectum Date: 2006-11 Impact factor: 4.585
Authors: Shuji Ogino; Takako Kawasaki; Mohan Brahmandam; Mami Cantor; Gregory J Kirkner; Donna Spiegelman; G Mike Makrigiorgos; Daniel J Weisenberger; Peter W Laird; Massimo Loda; Charles S Fuchs Journal: J Mol Diagn Date: 2006-05 Impact factor: 5.568
Authors: S Ogino; M Cantor; T Kawasaki; M Brahmandam; G J Kirkner; D J Weisenberger; M Campan; P W Laird; M Loda; C S Fuchs Journal: Gut Date: 2006-01-11 Impact factor: 23.059
Authors: Teppei Morikawa; Aya Kuchiba; Mai Yamauchi; Jeffrey A Meyerhardt; Kaori Shima; Katsuhiko Nosho; Andrew T Chan; Edward Giovannucci; Charles S Fuchs; Shuji Ogino Journal: JAMA Date: 2011-04-27 Impact factor: 56.272
Authors: E J Th Belt; E A te Velde; O Krijgsman; R P M Brosens; M Tijssen; H F van Essen; H B A C Stockmann; H Bril; B Carvalho; B Ylstra; H J Bonjer; G A Meijer Journal: Ann Surg Oncol Date: 2011-10-12 Impact factor: 5.344
Authors: Alexander Arnold; Matthias Kloor; Lina Jansen; Jenny Chang-Claude; Hermann Brenner; Moritz von Winterfeld; Michael Hoffmeister; Hendrik Bläker Journal: Virchows Arch Date: 2017-05-23 Impact factor: 4.064
Authors: Kim F Rhoads; Leland K Ackerson; Justine V Ngo; Florette K Gray-Hazard; S V Subramanian; R Adams Dudley Journal: Med Care Date: 2013-12 Impact factor: 2.983
Authors: Danielle M Hari; Anna M Leung; Ji-Hey Lee; Myung-Shin Sim; Brooke Vuong; Connie G Chiu; Anton J Bilchik Journal: J Am Coll Surg Date: 2013-06-12 Impact factor: 6.113
Authors: K Søndenaa; P Quirke; W Hohenberger; K Sugihara; H Kobayashi; H Kessler; G Brown; V Tudyka; A D'Hoore; R H Kennedy; N P West; S H Kim; R Heald; K E Storli; A Nesbakken; B Moran Journal: Int J Colorectal Dis Date: 2014-01-31 Impact factor: 2.571
Authors: Marianne Berg; Marianne Guriby; Oddmund Nordgård; Bjørn S Nedrebø; Terje C Ahlquist; Rune Smaaland; Satu Oltedal; Jon Arne Søreide; Hartwig Kørner; Ragnhild A Lothe; Kjetil Søreide Journal: Mol Med Date: 2013-09-10 Impact factor: 6.354